Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REGADENOSON for Coronary artery disease: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 25 adverse event reports in the FDA FAERS database where REGADENOSON was used for Coronary artery disease.

Most Reported Side Effects for REGADENOSON

Side Effect Reports % Deaths Hosp.
Nausea 311 10.1% 5 28
Dyspnoea 271 8.8% 8 43
Seizure 247 8.0% 8 42
Vomiting 233 7.6% 6 17
Injection site extravasation 226 7.4% 1 0
Hypotension 200 6.5% 4 15
Headache 190 6.2% 2 17
Cardiac arrest 183 6.0% 15 30
Dizziness 160 5.2% 0 19
Blood pressure decreased 143 4.7% 0 15
Chest pain 143 4.7% 4 38
Tremor 139 4.5% 0 27
Bradycardia 122 4.0% 6 16
Loss of consciousness 119 3.9% 2 19
Unresponsive to stimuli 110 3.6% 7 22

Other Indications for REGADENOSON

Product used for unknown indication (1,545) Cardiac stress test (634) Scan myocardial perfusion (629) Chest pain (60) Diagnostic procedure (19) Cardiac pharmacologic stress test (14) Cardiovascular disorder (14) Dyspnoea (14) Positron emission tomogram (12) Angina pectoris (11)

Other Drugs Used for Coronary artery disease

ASPIRIN (2,758) CLOPIDOGREL BISULFATE (1,584) EVOLOCUMAB (1,266) ATORVASTATIN (891) RIVAROXABAN (847) DILTIAZEM (664) ROSUVASTATIN (600) TICAGRELOR (520) QUINAPRIL (511) AMLODIPINE (486)

Related Pages

REGADENOSON Full Profile All Coronary artery disease Drugs REGADENOSON Demographics REGADENOSON Timeline